Menthacarin, a proprietary peppermint oil and caraway oil combination, improves multiple complaints in patients with functional gastrointestinal disorders – a systematic review and meta-analysis

Abstract

Introduction: This systematic review summarizes published data on Menthacarin, the proprietary combination of peppermint oil and caraway oil, in the treatment of functional gastrointestinal disorders. Efficacy was assessed by meta-analysis of placebo-controlled trials. Methods: We searched Pubmed, Cochrane library, and the manufacturer’s information system for clinical studies investigating the safety and efficacy of Menthacarin. Efficacy analyses included change from baseline of epigastric pain and general improvement of the patients’ condition. Results: Five randomized trials involving 580 patients were found, demonstrating significant effects of Menthacarin on symptoms of functional dyspepsia (FD) compared to placebo or similar effects compared to a reference drug. Seven other studies reported favorable results on therapeutic application in FD patients with concomitant Helicobacter pylori infection, in irritable bowel syndrome (IBS), and on tolerability in FD patients from 12 years of age. Three trials in FD with 249 patients were eligible for meta-analysis. Results demonstrate a significant reduction in pain intensity (SMD 0.80; 95% CI: 0.39-1.21) and in item 2 of the Clinical Global Impression Scale (RR 2.65; 95% CI: 1.81-3.87) for Menthacarin. Conclusions: Menthacarin was shown to be effective and safe for the treatment of FD and represents a promising option for symptoms of IBS.